Biosyntech (Biosyntech) EBIT per Share : $-0.11 (TTM As of Dec. 2009)

View and export this data going back to 2000. Start your Free Trial

What is Biosyntech EBIT per Share?

Biosyntech's EBIT per Share for the three months ended in Dec. 2009 was $-0.03. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2009 was $-0.11.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Biosyntech's EBIT per Share or its related term are showing as below:

BSYI's 3-Year EBIT Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.5
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Biosyntech's EBIT for the three months ended in Dec. 2009 was $-3.17 Mil.

Biosyntech EBIT per Share Historical Data

The historical data trend for Biosyntech's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech EBIT per Share Chart

Biosyntech Annual Data

Trend

Mar00

Mar01

Mar02

Mar03

Mar04

Mar05

Mar06

Mar07

Mar08

Mar09

EBIT per Share

Get a 7-Day Free Trial

-0.11

-0.13

-0.08

-0.10

-0.09

Biosyntech Quarterly Data
	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09
EBIT per Share	Get a 7-Day Free Trial															-0.03	-0.02	-0.02	-0.03	-0.03

Biosyntech EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Biosyntech's EBIT per Share for the fiscal year that ended in Mar. 2009 is calculated as

	EBIT per Share		(A: Mar. 2009 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-8.723	/	95.902
=	-0.09

Biosyntech's EBIT per Share for the quarter that ended in Dec. 2009 is calculated as

	EBIT per Share		(Q: Dec. 2009 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.17	/	106.082
=	-0.03

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.11

Biosyntech (OTCPK:BSYI) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Biosyntech EBIT per Share Related Terms

Thank you for viewing the detailed overview of Biosyntech's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyntech (Biosyntech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3

Website

http://www.biosyntech.com

Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines